drugset / Trial / NCT06034626

Therapeutic Effectiveness of Different Machines in Intense Pulsed Light Treatment of Meibomian Gland Dysfunction

NCT06034626

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aimed to determine the therapeutic effectiveness of different machines in intense pulsed light (IPL) treatment of meibomian gland dysfunction (MGD). Subjects diagnosed with MGD underwent three sessions of IPL treatment in a control (M22) treatment group or experimental (OPL-I) treatment group and were followed up three to four weeks after each session. Tear breakup time (TBUT), meibomian gland secretion scores (MGSS), meibomian gland meibum scores (MGMS), corneal fluorescein staining (CFS) scores, and the Standard Patient Evaluation of Eye Dryness (SPEED) was used to assess eye dryness signs and symptoms at baseline and follow-up visits.

Timeline

Start
2020-11-03
Primary completion
2021-08-10
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Background Hyaluronic Acid Other / unclassified 0.3 % Topical

Indications